Latest Heart valve Stories

CONROE, Texas, April 6 /PRNewswire-FirstCall/ -- Hemiwedge Industries, Inc. (Pink Sheets: HWEG), a global supplier of engineered valves, today announced the appointment of Rodney W. Eads to its Advisory Board of Directors. Mr. Rodney W. Eads has over 35 years of experience in upstream energy business. The majority of his career has been with Exxon, serving 20 years in engineering and operations management primarily focused on drilling and completions of oil and gas wells. For the past...

KAIFENG, China, March 25 /PRNewswire-Asia-FirstCall/ -- China Valves Technology, Inc. (Nasdaq: CVVT) ("China Valves" or the "Company"), a leading Chinese metal valve manufacturer, today announced the Company will host a conference call at 9:00 a.m. Eastern Time on Monday, March 29, 2010 to discuss its financial results for the fourth quarter and fiscal year ended on December 31, 2009. The call will be hosted by Ms. Ichi Shih, Chief Financial Officer, Mr. Jianbao Wang, General...

MINNEAPOLIS, March 22 /PRNewswire-FirstCall/ -- ATS Medical, Inc. (Nasdaq: ATSI), manufacturer and marketer of state-of-the-art cardiac surgery products and services today announced that Health Canada-Medical Device Bureau, Therapeutic Products Programme has approved commercialization of the ATS Simulus® Annuloplasty Product Line for valve repair. (Logo: http://www.newscom.com/cgi-bin/prnh/20040202/ATSILOGO) The Simulus product portfolio includes flexible, semi-rigid and adjustable...

EVANSTON, Ill., March 14 /PRNewswire/ -- NorthShore University HealthSystem (NorthShore) interventional cardiologist, Ted Feldman, MD, presented data today at the American College of Cardiology annual scientific sessions from the EVEREST II trial (Endovascular Valve Edge-to-Edge REpair STudy) demonstrating the MitraClip, a novel, first-in-class catheter-based device, is a safe and effective alternative to open heart surgery for select patients with mitral regurgitation. "This is a major...

LOS ANGELES, March 12 /PRNewswire/ -- For patients who are living with a heart problem, the option of surgical treatment can be just as terrifying as their current condition. From aortic aneurysms to Heart Valve Replacement Surgery, Open Heart Surgery is a serious procedure that has definite risks to the patient's health. However, with a great team of talented and experienced cardiothoracic surgeons, patients who need heart valve replacement surgery can go into surgery feeling confident. At...

A significant number of people with heart disease will benefit from less invasive transcatheter heart valve replacements in future, finds a review of updated practices in CMAJ (Canadian Medical Association Journal).The most effective treatment for aortic stenosis, a common heart condition that shows with angina, loss of consciousness due to lack of blood flow, congestive heart failure, or sudden death, is valve replacement. However, large cohorts of people are never referred for this surgery...

MINNEAPOLIS, March 1 /PRNewswire-FirstCall/ -- ATS Medical, Inc. (Nasdaq: ATSI), manufacturer and marketer of state-of-the-art cardiac surgery products and services today announced the first human robot assisted endoscopic aortic valve replacement in the Midwest using the daVinci® Surgical System from Intuitive Surgical (Nasdaq: ISRG) to implant the ATS 3f ® Aortic Bioprosthesis. The procedure was recently performed by Husam H. Balkhy, M.D., at the Wisconsin Heart Hospital in...

WASHINGTON, Feb. 12 /PRNewswire-USNewswire/ -- NASA's White Sands Test Facility (WSTF) in Las Cruces, New Mexico has added a National Board Inspection Code (NBIC)-certified Valve Repair Facility to its array of spacecraft, component and propulsion system test and evaluation capabilities.(Logo: http://www.newscom.com/cgi-bin/prnh/20081007/38461LOGO)The test facility's new Component Services Section (CSS) Valve Repair Facility has received the National Board's certification to repair and...

OR YEHUDA, Israel, Feb. 9 /PRNewswire/ -- Valtech Cardio Ltd. announced today that Bruce H. KenKnight, PhD has joined the Valtech team serving as President and Chief Executive Officer. This announcement comes on the heels of Valtech's recently announced Series B financing that totaled $17.8 million from new and existing investors (OXO Capital Valve Ventures, NGN Capital and Peregrine Ventures). Bruce has more than 25 years of experience in medical device research and development (R&D)...

OR YEHUDA, Israel, Feb. 2 /PRNewswire/ -- Valtech Cardio Ltd. announced today that new and existing investors (OXO Capital Valve Ventures LLC, NGN Biomed Opportunity II, L.P., and Peregrine VC Investments II, L.P.) recently completed a Series B financing of $17.8 million. Valtech Cardio Ltd. (Valtech) is engaged in development of a portfolio of minimally-invasive surgical and transcatheter mitral valve repair and replacement technologies designed to correct or significantly improve mitral...